Adjuvant treatment recommendations for patients with ER-positive/HER2-negative early breast cancer by Swiss tumor boards using the 21-gene recurrence score (SAKK 26/10). (Q33560459)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Adjuvant treatment recommendations for patients with ER-positive/HER2-negative early breast cancer by Swiss tumor boards using the 21-gene recurrence score (SAKK 26/10). |
scientific article |
Statements
Adjuvant treatment recommendations for patients with ER-positive/HER2-negative early breast cancer by Swiss tumor boards using the 21-gene recurrence score (SAKK 26/10) (English)
Swiss Group for Clinical Cancer Research (SAKK)
Bernhard C Pestalozzi
Christoph Tausch
Konstantin J Dedes
Christoph Rochlitz
Stefan Zimmermann
Roger von Moos
Ralph Winterhalder
Thomas Ruhstaller
Andreas Mueller
Katharina Buser
Markus Borner
Catrina Uhlmann Nussbaum
Bettina Seifert
Martin Bigler
Vincent Bize
Simona Berardi Vilei
Christoph Rageth
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference